Guru Ownership Trend
Guru Analysis for Iovance Biotherapeutics, Inc. (IOVA)
Iovance Biotherapeutics, Inc. (IOVA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $3.44 M.
Top institutional holders include Cliff Asness and Paul Tudor Jones.
Institutional sentiment is currently Bullish. This is evidenced by a $153,573.98 net inflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 464.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Iovance Biotherapeutics, Inc. (IOVA)
Major holders include Cliff Asness ($2.19 M), Paul Tudor Jones ($758,174). According to the latest reported data, 2 tracked investment managers collectively hold approximately 840,172 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $153,573.98, with 2 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 1 fully exited IOVA. The total reported sell value was $1.78 M.
Yes, 0 managers opened new positions in IOVA, and 2 increased their existing holdings. The total reported buy value was $1.93 M.